Suspension from Quotation
Open PDF
| Stock | Microba Life Sciences Ltd (MAP.ASX) |
|---|---|
| Release Time | 23 Jun 2025, 10:56 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Microba Life Sciences Requests Suspension Pending Capital Raise
Key Points
- Microba Life Sciences requests voluntary suspension of trading
- Suspension is related to a proposed capital raise
- Suspension expected to be lifted by Tuesday, 24 June 2025
Full Summary
Microba Life Sciences Ltd (ASX:MAP) has requested a voluntary suspension of its securities on the Australian Securities Exchange (ASX), effective from the commencement of trading on Monday, 23 June 2025. The suspension is requested in relation to a proposed capital raise that the company is planning to announce. Microba has stated that the voluntary suspension is expected to be lifted no later than Tuesday, 24 June 2025, once the company is in a position to announce the details of the capital raise. The company has confirmed that it is not aware of any reason why the voluntary suspension should not be granted, and that there is no other information necessary to inform the market about the suspension at this time.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In